Skip to content
10-Q

Quarterly Report

Inari Medical, Inc.

0001531048-23-000031

← back to feed
Filed
Nov 1, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 27, 2023 57.59M sh
Current Liabilities Q3 2023 · Sep 30, 2023 $66.07M
Current Liabilities Q3 2023 · Dec 31, 2022 $56.17M
Total Liabilities Q3 2023 · Sep 30, 2023 $96.69M
Total Liabilities Q3 2023 · Dec 31, 2022 $87.15M
Current Assets Q3 2023 · Sep 30, 2023 $469.06M
Current Assets Q3 2023 · Dec 31, 2022 $422.91M
Total Assets Q3 2023 · Sep 30, 2023 $548.84M
Total Assets Q3 2023 · Dec 31, 2022 $504.15M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $60.22M
Shares Diluted Q3 2023 · Sep 30, 2022 53.49M sh
Shares Diluted Q3 2023 · Sep 30, 2022 52.55M sh
Capex Q3 2023 · Sep 30, 2022 $8.17M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$25.23M
Stockholders Equity Q3 2023 · Sep 30, 2022 $415.1M
Stockholders Equity Q3 2023 · Jun 30, 2022 $413.78M
Stockholders Equity Q3 2023 · Mar 31, 2022 $418.81M
Stockholders Equity Q3 2023 · Dec 31, 2021 $239.21M
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.19
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.45
Eps Basic Q3 2023 · Sep 30, 2022 −$0.19
Eps Basic Q3 2023 · Sep 30, 2022 −$0.45
Sga Expense Q3 2023 · Sep 30, 2022 $75.83M
Sga Expense Q3 2023 · Sep 30, 2022 $212.72M
Rd Expense Q3 2023 · Sep 30, 2022 $19.11M
Rd Expense Q3 2023 · Sep 30, 2022 $53.81M
Net Income Q3 2023 · Sep 30, 2022 −$10.15M
Net Income Q3 2023 · Sep 30, 2022 −$23.47M
Net Income Q3 2023 · Jun 30, 2022 −$10.19M
Net Income Q3 2023 · Mar 31, 2022 −$3.13M
Operating Income Q3 2023 · Sep 30, 2022 −$9.8M
Operating Income Q3 2023 · Sep 30, 2022 −$22.21M
Gross Profit Q3 2023 · Sep 30, 2022 $85.14M
Gross Profit Q3 2023 · Sep 30, 2022 $244.32M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $11.06M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $31.38M
Revenue Q3 2023 · Sep 30, 2022 $96.2M
Revenue Q3 2023 · Sep 30, 2022 $275.7M